Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells

Background: Recent studies have demonstrated a key role of vascular smooth muscle cell (VSMC) dysfunction in atherosclerosis. Cyclin-dependent kinases 9 (CDK9), a potential biomarker of atherosclerosis, was significantly increased in coronary artery disease patient serum and played an important role...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shushi, Luo, Wu, Wu, Gaojun, Shen, Qirui, Zhuang, Zaishou, Yang, Daona, Qian, Jinfu, Hu, Xiang, Cai, Yan, Chattipakorn, Nipon, Huang, Weijian, Liang, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221363/
https://www.ncbi.nlm.nih.gov/pubmed/34102609
http://dx.doi.org/10.18632/aging.202998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221363/
https://www.ncbi.nlm.nih.gov/pubmed/34102609
http://dx.doi.org/10.18632/aging.202998

Ejemplares similares